SRRT
Serrate RNA effector molecule homolog
Also known as: ARS2, Asr2, serrate, SRRT_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BXP5
- Gene
- SRRT
- Ensembl
- ENSG00000087087
- Chromosome
- 7
- Canonical length
- 876 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Enables mRNA cap binding complex binding activity and protein-macromolecule adaptor activity. Involved in primary miRNA processing. Located in nucleoplasm. Part of ribonucleoprotein complex. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
876 residues, UniProt reviewed canonical sequence.
>Q9BXP5|SRRT
1 MGDSDDEYDR RRRDKFRRER SDYDRSRERD ERRRGDDWND REWDRGRERR SRGEYRDYDR
61 NRRERFSPPR HELSPPQKRM RRDWDEHSSD PYHSGYEMPY AGGGGGPTYG PPQPWGHPDV
121 HIMQHHVLPI QARLGSIAEI DLGVPPPVMK TFKEFLLSLD DSVDETEAVK RYNDYKLDFR
181 RQQMQDFFLA HKDEEWFRSK YHPDEVGKRR QEARGALQNR LRVFLSLMET GWFDNLLLDI
241 DKADAIVKML DAAVIKMEGG TENDLRILEQ EEEEEQAGKP GEPSKKEEGR AGAGLGDGER
301 KTNDKDEKKE DGKQAENDSS NDDKTKKSEG DGDKEEKKED SEKEAKKSSK KRNRKHSGDD
361 SFDEGSVSES ESESESGQAE EEKEEAEEAL KEKEKPKEEE WEKPKDAAGL ECKPRPLHKT
421 CSLFMRNIAP NISRAEIISL CKRYPGFMRV ALSEPQPERR FFRRGWVTFD RSVNIKEICW
481 NLQNIRLREC ELSPGVNRDL TRRVRNINGI TQHKQIVRND IKLAAKLIHT LDDRTQLWAS
541 EPGTPPLPTS LPSQNPILKN ITDYLIEEVS AEEEELLGSS GGAPPEEPPK EGNPAEINVE
601 RDEKLIKVLD KLLLYLRIVH SLDYYNTCEY PNEDEMPNRC GIIHVRGPMP PNRISHGEVL
661 EWQKTFEEKL TPLLSVRESL SEEEAQKMGR KDPEQEVEKF VTSNTQELGK DKWLCPLSGK
721 KFKGPEFVRK HIFNKHAEKI EEVKKEVAFF NNFLTDAKRP ALPEIKPAQP PGPAQILPPG
781 LTPGLPYPHQ TPQGLMPYGQ PRPPILGYGA GAVRPAVPTG GPPYPHAPYG AGRGNYDAFR
841 GQGGYPGKPR NRMVRGDPRA IVEYRDLDAP DDVDFFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SRRT can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.5
- Highest tissue expression
- 154 nTPM
Expression across tissuesHPA
Tissue
- testis: 154 nTPM
- bone marrow: 109 nTPM
- liver: 74 nTPM
- spleen: 73 nTPM
- prostate: 72 nTPM
- cerebellum: 70 nTPM
Single-cell type
- late spermatids: 450 nCPM
- late primary spermatocytes: 313 nCPM
- early spermatids: 244 nCPM
- erythrocyte progenitors: 95 nCPM
- early primary spermatocytes: 90 nCPM
- megakaryocyte progenitors: 78 nCPM
Immune cell
- memory CD8 T-cell: 39 nTPM
- gdT-cell: 28 nTPM
- naive CD8 T-cell: 23 nTPM
- intermediate monocyte: 23 nTPM
- eosinophil: 22 nTPM
- total PBMC: 21 nTPM
Brain region
- white matter: 50 nTPM
- cerebellum: 49 nTPM
- medulla oblongata: 48 nTPM
- basal ganglia: 47 nTPM
- hypothalamus: 47 nTPM
- thalamus: 45 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.36
- gnomAD pLI
- 0.59
- gnomAD missense Z
- 2.97
- DepMap mean gene effect
- -0.85
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- neuronal stem cell population maintenance
- positive regulation of neurogenesis
- primary miRNA processing
- regulation of DNA-templated transcription
- response to arsenic-containing substance
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- RNA-binding domain superfamily
- SERRATE/Ars2 , C-terminal
- SERRATE/Ars2, N-terminal
- SERRATE/Ars2
- Arsenite-resistance protein 2
- SERRATE/Ars2, N-terminal domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SRRT in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SRRT as an antibody target. Whether an autoantibody or antibody against SRRT could matter depends on whether native SRRT is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SRRT is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SRRT as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...